[ORGANIZATION]
GLP-1 receptor agonists
Featured in 17 tracked stories · first seen
Situations
Expanding therapeutic uses and regulatory concerns for GLP-1
43 clusters · 183 sources · last updated
Latest: Semaglutide shows efficacy in treating obesity in children aged 6 to 11
Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow
GLP-1 drugs: clinical trends, safety, and market shifts
342 clusters · 1316 sources · last updated
Latest: GLP-1 medications linked to diverse health outcomes and access challenges
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
GLP-1 receptor agonist research and safety scrutiny
13 clusters · 72 sources · last updated
Latest: FDA requires GLP-1 medication warnings for rare eye condition
Research into GLP-1 receptor agonists (GLP-1 RAs) continues to expand, investigating benefits beyond glycemic control and weight loss. Potential advantages include cardiovascular protection, kidney support, reduction in
Also covered in
-
GLP-1 Drugs Linked to Lower Fracture Risk in US Adults with Type 2 Diabetes
[HEALTH] · 9 sources ·
-
India's Narcotics Control Bureau warns of rising chemsex trend among youth
[HEALTH] · 7 sources ·